Noble Roman's, Inc.
NROM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 24.32 | -0.02 | 0.02 | -0.17 |
| FCF Yield | 10.46% | 21.40% | -8.46% | 0.75% |
| EV / EBITDA | 9.41 | 5.40 | 14.39 | 7.38 |
| Quality | ||||
| ROIC | 0.19% | 20.65% | 2.13% | 12.60% |
| Gross Margin | 30.71% | 38.52% | 21.08% | 31.57% |
| Cash Conversion Ratio | -282.60 | 1.07 | -0.03 | 2.98 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.58% | 1.16% | 7.80% | 5.86% |
| Free Cash Flow Growth | -48.45% | 428.15% | -791.24% | 116.91% |
| Safety | ||||
| Net Debt / EBITDA | 5.49 | 3.35 | 10.27 | 4.38 |
| Interest Coverage | 0.90 | 1.97 | 0.23 | 1.28 |
| Efficiency | ||||
| Inventory Turnover | 10.64 | 9.15 | 11.43 | 9.56 |
| Cash Conversion Cycle | 31.45 | 29.44 | 31.92 | 31,179.25 |